Physician profile
Luis Tobon
NPI 1851385967
$297.41
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.64 · 2020: $41.61 · 2021: $41.32 · 2022: $89.18 · 2023: $36.18 · 2024: $32.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $68.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $68.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $84.23 | 2019-2022 | |
| Hologic Sales and Service, LLC | $60.93 | 2020-2023 | Aptima, Thinprep 2000 Processor |
| Pfizer INC. | $37.27 | 2022 | |
| Astellas Pharma US INC | $32.48 | 2024 | Veozah |
| Avion Pharmaceuticals | $24.34 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.78 | 2019 | |
| Agile Therapeutics, INC. | $14.08 | 2023 | Twirla |
| Amag Pharmaceuticals, INC. | $12.36 | 2020 | |
| Minerva Surgical, INC | $11.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Tobon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.